COVID-19 shatters decades of global health progress, slashing life expectancy

FHS
April 8, 2024
3:32 am

Study in The Lancet reveals COVID-19 as the second leading cause of death in 2021, disrupting three decades of progress in global health and reducing life expectancy by 2.2 years from 2019 to 2021 despite previous gains.

Brand drug naming faces challenges in emerging categories, expert says

As brand drug naming gets more difficult, some therapy areas like obesity and Alzheimer’s disease are facing even more challenges. That’s because both are traditionally

January 3, 2024

New model reveals mechanisms of lung injury from mechanical ventilation

For the first time, scientists are able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the lungs.

September 19, 2024

Study identifies key factor in lung and eye damage in preemies

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.